Prolonged Glucose Normalization of Streptozotocin-Induced Diabetic Mice by Transplantation of Rat Islets Coencapsulated with Crosslinked Hemoglobin

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Transplantation

• Publication date

  2004-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.TP.0000128617.14309.26PMID 15316367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protection of insulin secreting cells from nitric oxide induced cellular damage by crosslinked hemoglobin.

  2004cited by this paper
• Effect of Cross-Linked Hemoglobin on Functionality and Viability of Microencapsulated Pancreatic Islets

  2002influential reference
• Prevention of Early Islet Graft Failure by Selective Inducible Nitric Oxide Synthase Inhibitors after Pig to Nude Rat Intraportal Islet Transplantation. Transplantation 2001; 71: 179???184.: Brandhorst D, Brandhorst H, Zwolinski A, Nahidi F, Bretzel RG

  2001cited by this paper
• The Effect of Zinc-Crystallized Glucagon-Like Peptide-1 on Insulin Secretion of Macroencapsulated Pancreatic Islets

  2001cited by this paper
• PREVENTION OF EARLY ISLET GRAFT FAILURE BY SELECTIVE INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS AFTER PIG TO NUDE RAT INTRAPORTAL ISLET TRANSPLANTATION1

  2001cited by this paper
• Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site.

  2001cited by this paper
• Cell transplantation for endocrine disorders.

  2000cited by this paper
• Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets.

  1999influential reference
• 19F‐MRI in vivo determination of the partial oxygen pressure in perfluorocarbon‐loaded alginate capsules implanted into the peritoneal cavity and different tissues

  1999cited by this paper
• Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?

  1999cited by this paper
• Biohybrid artificial pancreas based on macrocapsule device.

  1999cited by this paper
• In Situ Electrochemical Oxygen Generation with an Immunoisolation Device

  1999cited by this paper
• Synthesis of sulfonylurea conjugated copolymer via PEO spacer and its in vitro short-term bioactivity in insulin secretion from islets of Langerhans.

  1998cited by this paper
• Glucose and Tolbutamide Induce Apoptosis in Pancreatic β-Cells

  1998cited by this paper
• Actual perspectives in biohybrid artificial pancreas for the therapy of type 1, insulin-dependent diabetes mellitus.

  1998cited by this paper
• Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration.

  1998cited by this paper
• Immunoisolation Strategies for the Transplantation of Pancreatic Islets

  1997cited by this paper
• Facilitated oxygen transport with modified and encapsulated hemoglobins across non-flowing solution membrane.

  1997cited by this paper
• Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets

  1997cited by this paper
• Transplantation of pancreatic islets.

  1997cited by this paper
• Effect of microencapsulation on oxygen distribution in islets organs.

  1994cited by this paper
• Immobilized hemoglobin improves islet function and viability in the bioartificial pancreas in vitro and in vivo.

  1994cited by this paper
• Effect of Hypoxia on Insulin Secretion by Isolated Rat and Canine Islets of Langerhans

  1993cited by this paper
• Xenografts of rat islets into diabetic mice. An evaluation of new smaller capsules.

  1992cited by this paper
• Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion.

  1992cited by this paper
• β-Cell Dysfunction Induced by Chronic Hyperglycemia: Current Ideas on Mechanism of Impaired Glucose-Induced Insulin Secretion

  1992cited by this paper
• Xenotransplantation of microencapsulated fetal rat islets.

  1991cited by this paper
• Bioengineering in development of the hybrid artificial pancreas.

  1991cited by this paper
• Morphological Evidence for Pancreatic Polarity of β-Cell Within Islets of Langerhans

  1988cited by this paper
• Synthetic carriers of oxygen.

  1987cited by this paper
• Encapsulation of Rat Islets of Langerhans Prolongs Xenograft Survival in Diabetic Mice

  1986cited by this paper
• Transplantation of pancreatic islets.

  1984cited by this paper
• New Perspectives on the Microvasculature of the Islets of Langerhans in the Rat

  1982cited by this paper
• Dynamics of O2 consumption in rat pancreatic islets

  1980cited by this paper

• Advances in alginate encapsulation of pancreatic islets for immunoprotection in type 1 diabetes

  2023cites this paper
• Hydrogels in Emerging Technologies for Type 1 Diabetes.

  2020cites this paper
• Nanotechnology in cell replacement therapies for type 1 diabetes.

  2019cites this paper
• Islet encapsulation.

  2018cites this paper
• Advances in Local Drug Release and Scaffolding Design to Enhance Cell Therapy for Diabetes

  2015cites this paper
• Oxygen Supply by Photosynthesis to an Implantable Islet Cell Device

  2014cites this paper
• Oxygen supply to encapsulated therapeutic cells.

  2014cites this paper
• Microencapsulation of Porcine Pancreatic Islets and Its Application to Bio-Artificial Pancreas

  2014cites this paper
• Challenges in the Development of Immunoisolation Devices

  2014cites this paper
• Poly(ethylene glycol) cross‐linked hemoglobin with antioxidant enzymes protects pancreatic islets from hypoxic and free radical stress and extends islet functionality

  2012cites this paper
• Encapsulation of Cells (Cellular Delivery) Using Sol–Gel Systems

  2011cites this paper
• Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation.

  2010cites this paper
• Synthesis and characterization of hemoglobin conjugates with antioxidant enzymes via poly(ethylene glycol) cross-linker (Hb-SOD-CAT) for protection from free radical stress.

  2010cites this paper
• Eliminating oxygen supply limitations for transplanted microencapsulated islets in the treatment of type 1 diabetes

  2008cites this paper
• Challenges and emerging technologies in the immunoisolation of cells and tissues.

  2008cites this paper
• 55 – Cell-Based Drug Delivery

  2008cites this paper
• Perfluorocarbons: new tool for islets preservation in vitro.

  2008cites this paper
• 7 – Encapsulated Human Islet Allografts: Providing Safety with Efficacy

  2007cites this paper
• Chapter Twenty-Nine – Engineering Challenges in Immunobarrier Device Development

  2007cites this paper
• Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb

  2005cites this paper
• Intrasplenic Transplantation of Encapsulated Genetically Engineered Mouse Insulinoma Cells Reverses Streptozotocin-Induced Diabetes in Rats

  2005cites this paper
• Intrasplenic transplantation of encapsulated genetically engineered mouse insulinoma cells reverses streptozotocin-induced diabetes in rats.

  2005cites this paper